| 臺大學術典藏 |
2021-09-16T01:51:54Z |
Treatment of Vasospasm After Aneurysmal Subarachnoid Hemorrhage: Two Cases of Successful Reverse Vasospasm by Intra - Arterial Nimodipine After Aneurysmal Subarachnoid Hemorrhage
|
Pai T.-Y.; YU-JU TSENG |
| 國立臺灣大學 |
1993-03 |
Treatment of Vitreous Floaters with Neadymium YAG
|
蔡武甫; Chen, Yen-Chih; Su, Chong-Yi; Tsai, Wu-Fu; Chen, Yen-Chih; Su, Chong-Yi |
| 國立臺北護理健康大學 |
2002-10 |
Treatment of Vocal Fold Scarring: Rheological and Histological Measures of Homologous Collagen Matrix
|
Thibeault, Susan L.; VanGroll, Patrick J.; Kriesel, Kevin J.; Chan, Roger W.; Bless, Diane M.; Suzuki, Tatsutoshi; Ford, Charles N. |
| 臺北醫學大學 |
2006 |
Treatment of VWD patient with OHSS by abdominal tapping complicated by subcutaneous hematomas – Case report
|
曾啟瑞; Chen PH; Chuang CC; Chen D; Hsu HC; Tzeng CR; |
| 國立交通大學 |
2014-12-08T15:18:46Z |
Treatment of wastewater containing nano-scale silica particles by dead-end microfiltration: evaluation of pretreatment methods
|
Pan, JR; Huang, CP; Jiang, W; Chen, CS |
| 國立臺灣大學 |
1995-11 |
Treatment of Wastewater Containing Nitrophenol with Plug Flow Anaerobic Biofilter
|
Tseng, S.K.; W.E. Chang |
| 國立中山大學 |
1998-09 |
Treatment of wastewater using an admicellar enhanced CSTFR
|
C.L. Lee ;J.C. Lee |
| 元智大學 |
2013-02 |
Treatment of waters and wastewaters containing sulfur dyes: A review
|
T.A. Nguyen; Juang R.-S. |
| 臺北醫學大學 |
2006 |
Treatment of Woman with Adenomyosis by Debulking Surgery and Subsequent Gonadotropin-Releasing Hormone Agonist Therapy Preserves the Potential of Fertility and Achieves Good Pregnancy Outcomes.
|
曾啟瑞; Chen PH; Wang IT; Chen CS; Tang WL; Liu WM; Tzeng CR |
| 中國醫藥大學 |
2007-11-18 |
Treatment option in surgical menopause
|
葉聯舜(Lian-Shung Yeh) |
| 臺大學術典藏 |
2020 |
Treatment options for COVID-19: The reality and challenges
|
PO-REN HSUEH; Jean S.-S.;Lee P.-I.;Po-Ren Hsueh; Jean S.-S.; Lee P.-I. |
| 臺大學術典藏 |
2021-01-07T06:08:38Z |
Treatment options for COVID-19: The reality and challenges
|
Jean S.-S.; PING-ING LEE; Hsueh P.-R.; Jean S.-S.;Ping-Ing Lee;Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-04T06:11:49Z |
Treatment options for dual HCV/HBV coinfection
|
Liu C.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-24T09:31:46Z |
Treatment options for dual HCV/HBV coinfection
|
CHUN-JEN LIU; Kao J.-H. |
| 臺大學術典藏 |
2022-08-12T06:29:08Z |
Treatment options for primary breast cancer based on sophisticated philosophy - The importance of local controls
|
Huang C.-H.; KING-JEN CHANG |
| 臺大學術典藏 |
2021-03-11T07:58:24Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; JEN-CHANG KO; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-03-11T08:29:29Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; JEN-CHANG KO; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-03-11T08:34:15Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Wen Y.-F.; MENG-RUI LEE; Yang C.-Y.; Wang J.-Y.; JEN-CHANG KO; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-05-02T03:49:12Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; JIN-YUAN SHIH; Yu C.-J. |
| 臺大學術典藏 |
2021-05-02T04:37:07Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; JANN-YUAN WANG; Ko J.-C.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-17T02:50:52Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; MENG-RUI LEE; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-17T03:21:16Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
SHENG-KAI LIANG; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-17T05:56:03Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; LI-TA KENG; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-10-04T07:15:37Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; JEN-CHANG KO; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-11-29T05:55:31Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang, Sheng-Kai; Keng, Li-Ta; Chang, Chia-Hao; Wen, Yueh-Feng; Lee, Meng-Rui; CHING-YAO YANG; Wang, Jann-Yuan; Ko, Jen-Chung; Shih, Jin-Yuan; Yu, Chong-Jen |
| 臺大學術典藏 |
2021-05-02T03:29:21Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; CHONG-JEN YU |
| 臺大學術典藏 |
2021-02-02T09:21:39Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Wen, Yueh Feng; MENG-RUI LEE; Yang, Ching Yao; JANN-YUAN WANG; JEN-CHUNG KO; JIN-YUAN SHIH; CHONG-JEN YU |
| 臺大學術典藏 |
2021-02-08T08:05:08Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Jen-Chung Ko;Sheng-Kai Liang;Li-Ta Keng;Chia-Hao Chang;Yueh-Feng Wen ; Meng-Rui Lee ; Ching-Yao Yang ; Jann-Yuan Wang ; Jin-Yuan Shih ; Chong-Jen Yu; JEN-CHUNG KO; SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Yueh-Feng Wen ; Meng-Rui Lee ; Ching-Yao Yang ; Jann-Yuan Wang ; Jin-Yuan Shih ; Chong-Jen Yu |
| 臺大學術典藏 |
2022-06-27T06:59:38Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; CHONG-JEN YU |
| 國立臺灣大學 |
2004 |
Treatment Outcome and Pattern of Failure in 77 Patients with Sinonasal Natural Killer/T-Cell or T-Cell Lymphoma
|
李啟誠; 田蕙芬; 唐季祿; 姚明; 陳耀昌; 蘇益仁; 許世明; 洪瑞隆; LI, CHI-CHENG; TIEN, HWEI-FANG; TANG, JIH-LUH; YAO, MING; CHEN, YAO-CHANG; SU, IH-JEN; HSU, SU-MING; HONG, RUEY-LONG |
| 臺大學術典藏 |
2004 |
Treatment Outcome and Pattern of Failure in 77 Patients with Sinonasal Natural Killer/T-Cell or T-Cell Lymphoma
|
Hong R.-L.; Hsu S.-M.; Su I.-J.; Chen Y.-C.; Yao M.; Tang J.-L.; HWEI-FANG TIEN; Li C.-C. |
| 臺大學術典藏 |
2004 |
Treatment Outcome and Pattern of Failure in 77 Patients with Sinonasal Natural Killer/T-Cell or T-Cell Lymphoma
|
Li C.-C.; Tien H.-F.; Tang J.-L.; MING YAO; Chen Y.-C.; Su I.-J.; Hsu S.-M.; Hong R.-L. |
| 臺大學術典藏 |
2021-01-06T03:58:54Z |
Treatment Outcome and Pattern of Failure in 77 Patients with Sinonasal Natural Killer/T-Cell or T-Cell Lymphoma
|
Li C.-C.; Tien H.-F.; JIH-LUH TANG; Yao M.; Chen Y.-C.; Su I.-J.; Hsu S.-M.; Hong R.-L. |
| 臺大學術典藏 |
2021-05-26T09:08:15Z |
Treatment Outcome and Pattern of Failure in 77 Patients with Sinonasal Natural Killer/T-Cell or T-Cell Lymphoma
|
Li C.-C.; Tien H.-F.; Tang J.-L.; Yao M.; YAO-CHANG CHEN; Su I.-J.; Hsu S.-M.; Hong R.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:13Z |
Treatment Outcome and Pattern of Failure in 77 Patients with Sinonasal Natural Killer/T-Cell or T-Cell Lymphoma
|
Li C.-C.;Tien H.-F.;Tang J.-L.;Yao M.;Chen Y.-C.;Su I.-J.;Hsu S.-M.;Ruey-Long Hong; Li C.-C.; Tien H.-F.; Tang J.-L.; Yao M.; Chen Y.-C.; Su I.-J.; Hsu S.-M.; RUEY-LONG HONG |
| 國立臺灣大學 |
2006-09 |
Treatment outcome and patterns of failure in breast cancer patients with locoregional recurrence after mastectomy
|
Kuo, SH; Cheng, JC; Huang, CS; Kuo, WH; Chien, CR; Ting, LL; Cheng, AL; Chang, KJ; Lai, MK |
| 臺大學術典藏 |
2021-02-03T08:23:13Z |
Treatment outcome and patterns of failure in breast cancer patients with locoregional recurrence after mastectomy.
|
Kuo Sh;Chia-Hsien Cheng;Huang Cs;Kuo Wh;Chien Cr;Ting Ll;Cheng Al;Chang Kj;Lai Mk.; Kuo SH; CHIA-HSIEN CHENG; Huang CS; Kuo WH; Chien CR; Ting LL; Cheng AL; Chang KJ; Lai MK. |
| 國立成功大學 |
2023 |
Treatment outcome and prognostic factors analysis of carcinoma ex pleomorphic adenoma of major salivary glands
|
Chang, Y.-H.;Kuo, C.;Chang, T.-H.;Chen, M.-K.;Lin, J.-C. |
| 國立成功大學 |
2024-02 |
Treatment outcome and prognostic factors of external auditory canal squamous cell carcinoma: A retrospective study in a tertiary center
|
Huang;Yi-Ting;Wu;Jiunn-Liang;Chao;Wen-Yuan;Lee;Wei-Ting |
| 國立臺灣大學 |
2012 |
Treatment Outcome of Additional Dextran to Corticosteroid Therapy on Sudden Deafness: Propensity Score-Matched Cohort Analysis
|
Wang, Chi-Te; Chou, Hsu-Wen; Fang, Kai-Min; Lai, Mei-Shu; Cheng, Po-Wen; 賴美淑 |
| 國立成功大學 |
2020-03 |
Treatment Outcome of Bacteremia Due to Non-Carbapenemase-producing Carbapenem-Resistant Klebsiella pneumoniae Bacteremia: Role of Carbapenem Combination Therapy
|
Lee;Nan-Yao;Tsai;Chin-Shiang;Syue;Ling-Shan;Chen;Po-Lin;Li;Chia-Wen;Li;Ming-Chi;Ko;Wen-Chien |
| 國立成功大學 |
2020-03-01 |
Treatment Outcome of Bacteremia Due to Non–Carbapenemase-producing Carbapenem-Resistant Klebsiella pneumoniae Bacteremia: Role of Carbapenem Combination Therapy
|
李南瑤; Lee, N.-Y.;Tsai, C.-S.;Syue, L.-S.;Chen, P.-L.;Li, C.-W.;Li, M.-C.;Ko, W.-C. |
| 臺大學術典藏 |
2018-09-10T15:38:12Z |
Treatment Outcome of Colorectal Neuroendocrine Tumor
|
賴碩倫(Shuo-Lun Lai);洪基翔(Ji-Shiang Hung);黃約翰(John Huang);林本仁(Been-Ren Lin);梁金銅(Jin-Tung Liang); BEEN-REN LIN; Ji-Shiang Hung |
| 臺大學術典藏 |
2020-02-25T05:15:24Z |
Treatment Outcome of Colorectal Neuroendocrine Tumor
|
SHUO-LUN LAI; JI-SHIANG HUNG; JOHN HUANG; BEEN-REN LIN; JIN-TUNG LIANG |
| 臺大學術典藏 |
2022-01-10T05:47:41Z |
Treatment Outcome of Colorectal Neuroendocrine Tumor
|
SHUO-LUN LAI; JI-SHIANG HUNG; JOHN HUANG; BEEN-REN LIN; JIN-TUNG LIANG |
| 臺北醫學大學 |
2009 |
Treatment Outcome of Kala Azar Patients Treated with Sodium Antimony Gluconate Sag and Miltefosine in Eastern Terai of Nepal
|
Birendra Kumar Yadav; ZaforUllah Chowdhury; Shamsun Nahar; Mizanur Rahman |
| 國家衛生研究院 |
2017-12-14 |
Treatment outcome of non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae infections: A multicenter study in Taiwan
|
Su, CF;Chuang, C;Lin, YT;Chan, YJ;Lin, JC;Lu, PL;Huang, CT;Wang, JT;Chuang, YC;Siu, LK;Fung, CP |
| 臺大學術典藏 |
2018 |
Treatment outcome of non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae infections: a multicenter study in Taiwan
|
Siu L.K.; Fung C.-P.; Su C.-F.;Chuang C.;Lin Y.-T.;Chan Y.-J.;Lin J.-C.;Lu P.-L.;Huang C.-T.;Jann-Tay Wang;Chuang Y.-C.;Siu L.K.;Fung C.-P.; Su C.-F.; Chuang C.; Lin Y.-T.; Chan Y.-J.; Lin J.-C.; Lu P.-L.; Huang C.-T.; JANN-TAY WANG; Chuang Y.-C. |
| 臺大學術典藏 |
2020-02-17T08:50:49Z |
Treatment Outcome of Overactive Bladder Patients Receiving Antimuscarinic Therapy for More than One Year
|
Hsiao S.-M; HO-HSIUNG LIN; Kuo H.-C. |
| 臺大學術典藏 |
2021-03-03T03:00:50Z |
Treatment Outcome of Overactive Bladder Patients Receiving Antimuscarinic Therapy for More than One Year
|
Hsiao S.-M.;Ho-Hsiung Lin;Kuo H.-C.; Hsiao S.-M.; HO-HSIUNG LIN; Kuo H.-C. |
